Literature DB >> 32132233

T cell responses induced by attenuated flavivirus vaccination are specific and show limited cross-reactivity with other flavivirus species.

Alba Grifoni1, Hannah Voic1, Sandeep Kumar Dhanda1, Conner K Kidd1, James D Brien2, Søren Buus3, Anette Stryhn3, Anna P Durbin4, Stephen Whitehead5, Sean A Diehl6, Aruna D De Silva1,7, Angel Balmaseda8, Eva Harris9, Daniela Weiskopf1, Alessandro Sette10,11.   

Abstract

Members of the flavivirus genus share a high level of sequence similarity and often circulate in the same geographical regions. However, whether T cells induced by one viral species cross-react with other related flaviviruses has not been globally addressed. Here, we tested pools of epitopes derived from dengue (DENV), zika (ZIKV), Japanese Encephalitis (JEV), West Nile (WNV), and yellow fever (YFV) viruses by Intracellular Cytokine Staining (ICS) using PBMCs of individuals naturally exposed to DENV or immunized with DENV (TV005) or YF17D vaccines. CD8 T cell responses recognized epitopes from multiple flaviviruses, however, the magnitude of cross-reactive responses was consistently several-fold lower than those to the autologous epitope pools, and associated with lower expression of activation markers such as CD40L, CD69, and CD137. Next, we characterized the antigen sensitivity of short-term T cell lines (TCL) representing twenty-nine different individual epitope/donor combinations. TCL derived from DENV monovalent vaccinees induced CD8 and CD4 T cells that cross-reacted within the DENV serocomplex but were consistently associated with more than 100-fold lower antigen sensitivity for most other flaviviruses, with no cross-recognition of YFV derived peptides. CD8 and CD4 TCL from YF17D vaccinees were associated with very limited cross-reactivity with any other flaviviruses, and in five out of eight cases more than 1000-fold lower antigen sensitivity. Overall, our data suggest limited cross-reactivity for both CD4 and CD8 T cell responses between flaviviruses and has implications for understanding immunity elicited by natural infection, and strategies to develop live attenuated vaccines against flaviviral species.ImportanceThe envelope (E) protein is the dominant target of neutralizing antibodies for dengue virus (DENV) and yellow fever virus (YFV). Accordingly, several DENV vaccine constructs use the E protein in a live attenuated vaccine format, utilizing a backbone derived from a heterologous flavivirus (such as YF) as a delivery vector. This backbone comprises the non-structural (NS) and capsid (C) antigens which are dominant targets of T cell responses. Here, we demonstrate that cross-reactivity at the level of T cell responses amongst different flaviviruses is very limited, despite high levels of sequence homology. Thus, the use of heterologous flavivirus species as a live attenuated vaccine vector is not likely to generate optimal T cell responses, and might thus impair vaccine performance.
Copyright © 2020 American Society for Microbiology.

Entities:  

Year:  2020        PMID: 32132233     DOI: 10.1128/JVI.00089-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

Review 1.  Epitope prediction and identification- adaptive T cell responses in humans.

Authors:  John Sidney; Bjoern Peters; Alessandro Sette
Journal:  Semin Immunol       Date:  2020-10-31       Impact factor: 11.130

2.  Transcriptomics of Acute DENV-Specific CD8+ T Cells Does Not Support Qualitative Differences as Drivers of Disease Severity.

Authors:  Alba Grifoni; Hannah Voic; Esther Dawen Yu; Jose Mateus; Kai Mei Yan Fung; Alice Wang; Grégory Seumois; Aruna D De Silva; Rashika Tennekon; Sunil Premawansa; Gayani Premawansa; Rashmi Tippalagama; Ananda Wijewickrama; Ashu Chawla; Jason Greenbaum; Bjoern Peters; Vijayanand Pandurangan; Daniela Weiskopf; Alessandro Sette
Journal:  Vaccines (Basel)       Date:  2022-04-14

Review 3.  Protection against dengue virus requires a sustained balance of antibody and T cell responses.

Authors:  Kristen M Valentine; Michael Croft; Sujan Shresta
Journal:  Curr Opin Virol       Date:  2020-08-13       Impact factor: 7.090

4.  Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers.

Authors:  Ricardo da Silva Antunes; Suresh Pallikkuth; Erin Williams; Esther Dawen Yu; Jose Mateus; Lorenzo Quiambao; Eric Wang; Stephen A Rawlings; Daniel Stadlbauer; Kaijun Jiang; Fatima Amanat; David Arnold; David Andrews; Irma Fuego; Jennifer M Dan; Alba Grifoni; Daniela Weiskopf; Florian Krammer; Shane Crotty; Michael E Hoffer; Savita G Pahwa; Alessandro Sette
Journal:  J Infect Dis       Date:  2021-07-02       Impact factor: 5.226

5.  Differential T cell reactivity to seasonal coronaviruses and SARS-CoV-2 in community and health care workers.

Authors:  Ricardo da Silva Antunes; Suresh Pallikkuth; Erin Williams; Esther Dawen Yu; Jose Mateus; Lorenzo Quiambao; Eric Wang; Stephen A Rawlings; Daniel Stadlbauer; Kaijun Jiang; Fatima Amanat; David Arnold; David Andrews; Irma Fuego; Jennifer M Dan; Alba Grifoni; Daniela Weiskopf; Florian Krammer; Shane Crotty; Michael E Hoffer; Savita G Pahwa; Alessandro Sette
Journal:  medRxiv       Date:  2021-01-15

6.  Pre-existing Immunity to Japanese Encephalitis Virus Alters CD4 T Cell Responses to Zika Virus Inactivated Vaccine.

Authors:  Noemia S Lima; Damee Moon; Samuel Darko; Rafael A De La Barrera; Leyi Lin; Michael A Koren; Richard G Jarman; Kenneth H Eckels; Stephen J Thomas; Nelson L Michael; Kayvon Modjarrad; Daniel C Douek; Lydie Trautmann
Journal:  Front Immunol       Date:  2021-02-24       Impact factor: 7.561

Review 7.  Adaptive Immunity to Dengue Virus: Slippery Slope or Solid Ground for Rational Vaccine Design?

Authors:  Lucas Wilken; Guus F Rimmelzwaan
Journal:  Pathogens       Date:  2020-06-15

8.  Identification of Novel Yellow Fever Class II Epitopes in YF-17D Vaccinees.

Authors:  Jose Mateus; Alba Grifoni; Hannah Voic; Michael A Angelo; Elizabeth Phillips; Simon Mallal; John Sidney; Alessandro Sette; Daniela Weiskopf
Journal:  Viruses       Date:  2020-11-12       Impact factor: 5.048

9.  Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans.

Authors:  Alessandro Sette; Daniela Weiskopf; Jose Mateus; Alba Grifoni; Alison Tarke; John Sidney; Sydney I Ramirez; Jennifer M Dan; Zoe C Burger; Stephen A Rawlings; Davey M Smith; Elizabeth Phillips; Simon Mallal; Marshall Lammers; Paul Rubiro; Lorenzo Quiambao; Aaron Sutherland; Esther Dawen Yu; Ricardo da Silva Antunes; Jason Greenbaum; April Frazier; Alena J Markmann; Lakshmanane Premkumar; Aravinda de Silva; Bjoern Peters; Shane Crotty
Journal:  Science       Date:  2020-08-04       Impact factor: 47.728

Review 10.  Cross-reactive memory T cells and herd immunity to SARS-CoV-2.

Authors:  Marc Lipsitch; Yonatan H Grad; Alessandro Sette; Shane Crotty
Journal:  Nat Rev Immunol       Date:  2020-10-06       Impact factor: 108.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.